Edith M Heintjes

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Emergency Department

Angiotensin Converting Enzyme

Acute Heart Failure

Top Venues

Clinical epidemiology

Current medical research and opinion

Pharmo Institute

Erasmus MC (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pharmo Institute Oct 01 2005

Netherlands

Scientific research manager

Education History

Erasmus MC

Netherlands

PHD :: General Practice

Publications

Edith M Heintjes, Anastassia Anastassopoulou, Josephina G Kuiper, Aikaterini Bilitou, Fernie J A Penning-van Beest, Ron M C Herings, Maarten Jacobus Postma, Johan Wouter Jukema
Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the Netherlands. Current medical research and opinion (2022)
Willemien J Kruik-Kollöffel, Job van der Palen, Carine J M Doggen, Marissa C Van Maaren, H Joost Kruik, Edith M Heintjes, Kris L L Movig, Gerard C M Linssen
Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases. PloS one 15 (12) (2020)
Edith M Heintjes, Irene D Bezemer, Daniel Prieto-Alhambra, Elisabeth Smits, Helen P Booth, Daniel Dedman, Ying He, Fabian Hoti, Minna Vehkala, Stefan de Vogel, Noah Jamie Robinson, Kwame Appenteng, Fernie J A Penning-van Beest
Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries. Clinical epidemiology 12 (2020)